Log in to save to my catalogue

In vitro antineoplastic effects of auranofin in canine lymphoma cells

In vitro antineoplastic effects of auranofin in canine lymphoma cells

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9e33ceadf2164cba8d77ad9baf9d8d0f

In vitro antineoplastic effects of auranofin in canine lymphoma cells

About this item

Full title

In vitro antineoplastic effects of auranofin in canine lymphoma cells

Publisher

England: BioMed Central Ltd

Journal title

BMC cancer, 2018-05, Vol.18 (1), p.522-522, Article 522

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

The orally available gold complex auranofin (AF) has been used in humans, primarily as an antirheumatic/immunomodulatory agent. It has been safely administered to healthy dogs to establish pharmacokinetic parameters for oral administration, and has also been used as a treatment in some dogs with immune-mediated conditions. Multiple in vitro studies...

Alternative Titles

Full title

In vitro antineoplastic effects of auranofin in canine lymphoma cells

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9e33ceadf2164cba8d77ad9baf9d8d0f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9e33ceadf2164cba8d77ad9baf9d8d0f

Other Identifiers

ISSN

1471-2407

E-ISSN

1471-2407

DOI

10.1186/s12885-018-4450-2

How to access this item